348 related articles for article (PubMed ID: 36497448)
1. Splicing-Disrupting Mutations in Inherited Predisposition to Solid Pediatric Cancer.
Alba-Pavón P; Alaña L; Astigarraga I; Villate O
Cancers (Basel); 2022 Dec; 14(23):. PubMed ID: 36497448
[TBL] [Abstract][Full Text] [Related]
2. Alternative RNA splicing defects in pediatric cancers: new insights in tumorigenesis and potential therapeutic vulnerabilities.
Venkataramany AS; Schieffer KM; Lee K; Cottrell CE; Wang PY; Mardis ER; Cripe TP; Chandler DS
Ann Oncol; 2022 Jun; 33(6):578-592. PubMed ID: 35339647
[TBL] [Abstract][Full Text] [Related]
3. Genetic Predisposition to Solid Pediatric Cancers.
Capasso M; Montella A; Tirelli M; Maiorino T; Cantalupo S; Iolascon A
Front Oncol; 2020; 10():590033. PubMed ID: 33194750
[TBL] [Abstract][Full Text] [Related]
4. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
[TBL] [Abstract][Full Text] [Related]
5. Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing.
Auclair J; Busine MP; Navarro C; Ruano E; Montmain G; Desseigne F; Saurin JC; Lasset C; Bonadona V; Giraud S; Puisieux A; Wang Q
Hum Mutat; 2006 Feb; 27(2):145-54. PubMed ID: 16395668
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors.
Parsons DW; Roy A; Yang Y; Wang T; Scollon S; Bergstrom K; Kerstein RA; Gutierrez S; Petersen AK; Bavle A; Lin FY; López-Terrada DH; Monzon FA; Hicks MJ; Eldin KW; Quintanilla NM; Adesina AM; Mohila CA; Whitehead W; Jea A; Vasudevan SA; Nuchtern JG; Ramamurthy U; McGuire AL; Hilsenbeck SG; Reid JG; Muzny DM; Wheeler DA; Berg SL; Chintagumpala MM; Eng CM; Gibbs RA; Plon SE
JAMA Oncol; 2016 May; 2(5):616-624. PubMed ID: 26822237
[TBL] [Abstract][Full Text] [Related]
7. Rare germline alterations in cancer-related genes associated with the risk of multiple primary tumor development.
Villacis RAR; Basso TR; Canto LM; Pinheiro M; Santiago KM; Giacomazzi J; de Paula CAA; Carraro DM; Ashton-Prolla P; Achatz MI; Rogatto SR
J Mol Med (Berl); 2017 May; 95(5):523-533. PubMed ID: 28093616
[TBL] [Abstract][Full Text] [Related]
8. Determination of splice-site mutations in Lynch syndrome (hereditary non-polyposis colorectal cancer) patients using functional splicing assay.
Naruse H; Ikawa N; Yamaguchi K; Nakamura Y; Arai M; Ishioka C; Sugano K; Tamura K; Tomita N; Matsubara N; Yoshida T; Moriya Y; Furukawa Y
Fam Cancer; 2009; 8(4):509-17. PubMed ID: 19685281
[TBL] [Abstract][Full Text] [Related]
9. Intronic alterations in BRCA1 and BRCA2: effect on mRNA splicing fidelity and expression.
Chen X; Truong TT; Weaver J; Bove BA; Cattie K; Armstrong BA; Daly MB; Godwin AK
Hum Mutat; 2006 May; 27(5):427-35. PubMed ID: 16619214
[TBL] [Abstract][Full Text] [Related]
10. Germline mutations of renal cancer predisposition genes and clinical relevance in Chinese patients with sporadic, early-onset disease.
Wu J; Wang H; Ricketts CJ; Yang Y; Merino MJ; Zhang H; Shi G; Gan H; Linehan WM; Zhu Y; Ye D
Cancer; 2019 Apr; 125(7):1060-1069. PubMed ID: 30548481
[TBL] [Abstract][Full Text] [Related]
11. Differentiating pathogenic mutations from polymorphic alterations in the splice sites of BRCA1 and BRCA2.
Claes K; Poppe B; Machackova E; Coene I; Foretova L; De Paepe A; Messiaen L
Genes Chromosomes Cancer; 2003 Jul; 37(3):314-20. PubMed ID: 12759930
[TBL] [Abstract][Full Text] [Related]
12. Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.
Yehia L; Ni Y; Sesock K; Niazi F; Fletcher B; Chen HJL; LaFramboise T; Eng C
PLoS Genet; 2018 Apr; 14(4):e1007352. PubMed ID: 29684080
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes.
Henn J; Spier I; Adam RS; Holzapfel S; Uhlhaas S; Kayser K; Plotz G; Peters S; Aretz S
Hered Cancer Clin Pract; 2019; 17():5. PubMed ID: 30680046
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive detection of germline variants by MSK-IMPACT, a clinical diagnostic platform for solid tumor molecular oncology and concurrent cancer predisposition testing.
Cheng DT; Prasad M; Chekaluk Y; Benayed R; Sadowska J; Zehir A; Syed A; Wang YE; Somar J; Li Y; Yelskaya Z; Wong D; Robson ME; Offit K; Berger MF; Nafa K; Ladanyi M; Zhang L
BMC Med Genomics; 2017 May; 10(1):33. PubMed ID: 28526081
[TBL] [Abstract][Full Text] [Related]
15. Germline EMSY sequence alterations in hereditary breast cancer and ovarian cancer families.
Määttä KM; Nurminen R; Kankuri-Tammilehto M; Kallioniemi A; Laasanen SL; Schleutker J
BMC Cancer; 2017 Jul; 17(1):496. PubMed ID: 28738860
[TBL] [Abstract][Full Text] [Related]
16. Hereditary cancer genes are highly susceptible to splicing mutations.
Rhine CL; Cygan KJ; Soemedi R; Maguire S; Murray MF; Monaghan SF; Fairbrother WG
PLoS Genet; 2018 Mar; 14(3):e1007231. PubMed ID: 29505604
[TBL] [Abstract][Full Text] [Related]
17. A high proportion of DNA variants of BRCA1 and BRCA2 is associated with aberrant splicing in breast/ovarian cancer patients.
Sanz DJ; Acedo A; Infante M; Durán M; Pérez-Cabornero L; Esteban-Cardeñosa E; Lastra E; Pagani F; Miner C; Velasco EA
Clin Cancer Res; 2010 Mar; 16(6):1957-67. PubMed ID: 20215541
[TBL] [Abstract][Full Text] [Related]
18. Clinical Utility of Functional RNA Analysis for the Reclassification of Splicing Gene Variants in Hereditary Cancer.
Agiannitopoulos K; Pepe G; Papadopoulou E; Tsaousis GN; Kampouri S; Maravelaki S; Fassas A; Christodoulou C; Iosifidou R; Karageorgopoulou S; Markopoulos C; Natsiopoulos I; Papazisis K; Vasilaki-Antonatou M; Venizelos V; Ozmen V; Tansan S; Kaban K; Eniu DT; Chiorean A; Nasioulas G
Cancer Genomics Proteomics; 2021; 18(3):285-294. PubMed ID: 33893081
[TBL] [Abstract][Full Text] [Related]
19. Targeted RNA-seq successfully identifies normal and pathogenic splicing events in breast/ovarian cancer susceptibility and Lynch syndrome genes.
Brandão RD; Mensaert K; López-Perolio I; Tserpelis D; Xenakis M; Lattimore V; Walker LC; Kvist A; Vega A; Gutiérrez-Enríquez S; Díez O; ; de la Hoya M; Spurdle AB; De Meyer T; Blok MJ
Int J Cancer; 2019 Jul; 145(2):401-414. PubMed ID: 30623411
[TBL] [Abstract][Full Text] [Related]
20. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
